How Much Is Remicade Infusion Without Insurance? | Real-World Cost Map

Sticker shock hits fast with infliximab. The drug itself is priced per 100-mg vial, dosing scales with body weight, and the bill also includes facility time, infusion staff, supplies, and observation. Hospitals and office infusion centers publish different cash prices, and many post separate line items for the drug and the administration time. The ranges below show what self-pay patients commonly encounter and why the bill swings so widely.

Quick Range Check

Most adults start at 5 mg/kg. A 70-kg person usually needs four 100-mg vials per visit. Brand-name vials often sit near the $1,100 mark each on retail guides, while biosimilars list closer to ~$500 per 100 mg. Administration codes for chemo-class biologics add a few hundred dollars for the first hour and smaller charges for extra hours. When treatment happens inside a hospital outpatient department, the total often rises.

Typical Line Items And Cash Ranges

Item	What It Covers	Common Self-Pay Range
Drug Vials (Infliximab)	100-mg vials of brand or biosimilar	$500–$1,150 per 100 mg
Initial Infusion Hour (CPT 96413)	Chemo-level biologic administration, first hour	$500–$750 in clinics; hospitals can post higher
Each Additional Hour (CPT 96415)	Added time beyond the first hour	$100–$325 per hour
Facility/Chair Fees	Room, monitoring, supplies	$0–$1,500+ by site
Pharmacy/Handling	Reconstitution, compounding, disposables	$50–$300

Ranges reflect posted retail guides, clinic cash sheets, and published benchmarks for infusion codes, not negotiated rates. They illustrate why two patients can see bills that differ by thousands.

Remicade Infusion Price Without Coverage — What Drives It

1) Dose And Rounding To Full Vials

Vials come in 100-mg units. A 70-kg person at 5 mg/kg needs 350 mg, which rounds to four vials. That single rounding step flips the drug line from three to four vials and adds an extra vial to the bill. That alone can tack on ~$500–$1,150, depending on brand vs biosimilar.

2) Brand Name Versus Biosimilar

Retail list pages place brand vials near ~$1,100, while common biosimilars such as AVSOLA list near ~$500. Clinics with posted cash sheets echo that gap. Same molecule, different label and acquisition cost, and that difference flows straight into the self-pay total.

3) Site Of Care

Independent infusion centers often publish lower administration charges than hospital outpatient departments. Hospital cash schedules and machine-readable files can include higher facility fees, which lift the total even if the drug line is similar. The federal transparency rule requires hospitals to publish cash prices, so you can compare.

4) Time In The Chair

Infusions of chemo-class biologics bill the first hour with CPT 96413 and extra time with 96415. Longer visits add incremental charges. Clinic sheets often show several hundred dollars for the first hour and a smaller amount for each hour after that.

5) Market Benchmarks Versus Retail Sheets

Medicare sets a quarterly benchmark called Average Sales Price (ASP) for Part B drugs and pays ASP+6% to participating providers. ASP is not a cash price, yet it’s a useful reference for “what the market pays” before facility markups. When a clinic quotes self-pay, asking how it relates to the current ASP can anchor the conversation.

Build A Realistic Estimate

Use this step-by-step template to turn your weight and local quotes into a personal estimate you can compare across sites.

Step 1: Calculate Likely Vials

Multiply weight (kg) × dose (mg/kg), then round up to the next 100 mg. Divide by 100 to get vial count. A 70-kg adult at 5 mg/kg yields 350 mg → four vials.

Step 2: Pick A Market Price Per Vial

Check a retail guide or the clinic’s cash sheet for brand and for at least one biosimilar. The gap between ~$1,100 and ~$500 per 100 mg often sets the tone for the visit total.

Step 3: Add Infusion Time

Ask the site about charges tied to CPT 96413 (first hour) and 96415 (each additional hour). Two to three hours is common across regimens. Clinics may post a bundled “chair fee”; hospitals may separate facility time from staff time.

Step 4: Include Setup And Pharmacy Fees

Many centers add line items for IV setup, pharmacy handling, and supplies. They look small beside the drug line but still change the final number.

Worked Example (Self-Pay Clinic)

Scenario: 70-kg adult, 5 mg/kg (four vials), biosimilar at ~$500 per vial, first hour $600, one extra hour $150, $100 in supplies. Estimated total: $2,000 (drug) + $750 (time) + $100 (supplies) ≈ $2,850. A hospital outpatient department with higher facility fees can more than double that number.

Where Cash Quotes Tend To Land

Published clinic sheets and retail references put many self-pay visits near the low-to-mid thousands when biosimilars are used in non-hospital sites. Hospital outpatient visits, brand-name drug lines, dose escalation to 10 mg/kg, or long chair time can push totals into the five-figure range. That’s why people report $3,500 on the low end and $15,000–$20,000 on the high end.

How To Lower The Bill Today

Ask For A Biosimilar Cash Quote

Request the self-pay total for a biosimilar such as AVSOLA and compare it to brand. Many clinics list a per-vial cash price around half of the brand reference.

Price The Site Of Care

Call at least one independent infusion center and one hospital outpatient department. Ask for the cash total that includes the drug, infusion time, and any facility line. Hospitals must publish cash prices and payer-specific rates, so price-shopping is possible. Link your request to the exact codes (J1745 for infliximab units, 96413/96415 for administration).

Use ASP As A Conversation Anchor

Bring the current Medicare ASP reference and ask how the quoted price compares. Many clinics base self-pay on an internal markup over acquisition cost; ASP gives a shared baseline. You can find the latest quarter on the CMS ASP page. CMS ASP pricing files.

Ask About Prepay Discounts And Bundles

Some centers offer a discount for paying the full amount in advance or for buying a multi-infusion package. A written quote keeps add-ons in check.

Look For Assistance If Eligible

Manufacturer programs can’t pay the administration fee, but they may help with the medication portion in certain situations. For those with no coverage or limited coverage, J&J lists pathways that may reduce the drug cost component. See cost support options from J&J. Program rules apply and change over time.

Dose, Regimen, And Why Totals Change Over A Year

Induction uses three visits in the first six weeks, then maintenance repeats every eight weeks. If your dose increases to 10 mg/kg or your weight changes, vial counts shift. Over a year, those steps can double the medication spend. Clinics sometimes switch patients from brand to a biosimilar at the first maintenance dose to balance outcomes and budget.

Brand Versus Biosimilar: Per-Visit Drug Math (5 mg/kg, 70 kg)

Option	Vials Needed	Approx. Drug Line
Brand Reference (100 mg ≈ $1,100)	4	~$4,400
Biosimilar (100 mg ≈ $500)	4	~$2,000
Biosimilar, Dose Escalated To 10 mg/kg	8	~$4,000

Figures use retail guide list figures and a common body weight purely to illustrate how vial count and label choice swing totals; your clinic’s cash sheet governs the actual quote.

Decoding The Bill Codes You’ll See

Drug Units

Infliximab bills in 10-mg units under the J1745 code. A 400-mg dose posts as 40 units. That line is separate from the infusion time.

Infusion Time

The first hour of chemo-class biologic administration bills under CPT 96413. Each added hour bills under 96415. If a visit runs long, you’ll see more 96415 units.

Facility And Pharmacy

Hospitals may add internal revenue codes for room or observation; clinics may fold this into a chair fee. Pharmacy handling lines cover reconstitution and sterile supplies. These vary by site and often drive the widest gaps between quotes.

Sample Scenarios You Can Compare

Clinic Using A Biosimilar

Four vials at ~$500 ($2,000) + first hour $600 + one extra hour $150 + $100 supplies ≈ $2,850. If the visit requires more time or a second observation hour, add the site’s 96415 amount per hour.

Hospital Outpatient Using Brand

Four vials at ~$1,100 ($4,400) + first hour $700–$1,200 + facility/room $500–$1,500 + pharmacy/supplies $150–$300 → totals often land $6,000–$8,000+ for standard dosing, and far higher with dose escalation.

Using ASP To Judge A Quote

Print the current ASP table and circle the infliximab line. If a site quotes many multiples of ASP on the drug line and you’re paying cash, ask whether a biosimilar cash option is available or whether a different site can honor a lower acquisition-based rate. ASP pricing files.

Induction Versus Maintenance: Planning Cash Flow

The first six weeks include three visits, so the up-front spend concentrates early. After that, most people return every eight weeks. If your cash plan relies on assistance for the medication line only, remind the site that you will still owe the infusion time. J&J’s patient pages state that savings programs do not cover the cost to give the infusion.

What To Ask Before You Book

Request A Written, All-In Cash Quote

Ask for a single visit total that includes drug, infusion time, facility or chair fees, and supplies. If the site quotes only the drug, your final bill may surprise you.

Confirm Which Label You’ll Receive

Brand and biosimilar invoices look similar, yet the per-vial price can differ by half. Lock the label into the quote so the numbers don’t move on treatment day.

Ask About Dose Changes Over Time

If you may escalate to 10 mg/kg, price both scenarios now. You can spread induction across a payment plan and plan for the maintenance rhythm.

Check For Cash Discounts And Pay-In-Advance Rates

Many centers offer a prompt-pay discount. Some will match a local competitor’s biosimilar quote if you supply a written offer.

Bottom Line Pricing Map

Drug label, site of care, and time in chair drive the bill. Biosimilars at non-hospital sites often land in the lower thousands. Brand vials, hospital facility fees, and dose escalations push totals higher. Use ASP as a benchmark, request written quotes with the exact codes, and compare at least two sites. With those steps, many self-pay patients move a four-figure bill down by several thousand dollars.

References for readers: Medicare ASP methodology and quarterly tables and retail Remicade vial pricing data.